Lecanemab drug for Alzheimer
January 15 , 2023
605 days
408
- The US Food and Drug Administration has approved lecanemab (Leqembi) for treatment of Alzheimer’s disease.
- Lecanemab, which will be sold under the brand name Leqembi, is the first Alzheimer’s treatment of its kind.
![](https://www.tnpscthervupettagam.com/assets/home/media/general/original_image/Picture649.png)
Post Views:
408